The University of Southampton
University of Southampton Institutional Repository

The effect of intact vs hydrolysed collagen on recovery from exercise induced muscle damage: a double-blind, randomised, placebo-controlled trial

The effect of intact vs hydrolysed collagen on recovery from exercise induced muscle damage: a double-blind, randomised, placebo-controlled trial
The effect of intact vs hydrolysed collagen on recovery from exercise induced muscle damage: a double-blind, randomised, placebo-controlled trial
Collagen supplementation has the potential to aid in the recovery from exercise-induced muscle damage (EIMD). A novel collagen supplement, rich in intact type I collagen (Natiiv™, Trinsic Collagen Limited), potentially increases delivery of its constituent amino acids and intact alpha helices to the extracellular matrix (ECM) for remodelling. Thirty-six healthy, young and active adults (M = 27, age: 21.3 ± 4.3 years, body mass index; 25.2 ± 5.7 kg m−2) were assigned (1:1:1) in a double-blind, randomised, placebo-controlled trial, to consume either: Natiiv™ collagen (0.255 g·day−1 of Natiiv™ collagen), hydrolysed collagen (20 g·day−1 of collagen; Peptan®, Rousselot, Belgium), or placebo (collagen depleted alkaline water; Natiiv™), for 30-days. On day-28, muscle damage-inducing exercise (150 drop jumps) was undertaken. Exercise performance (counter movement, squat, and drop jumps), quadriceps strength (maximal voluntary isometric contraction; leg pain (visual analogue scale, pain pressure threshold, short recovery and stress scale questionnaire); and knee inflammation (via colour fraction ultrasonography) and systemic inflammation (IL-6, IL-10, TNFα); ECM damage (hydroxyproline) and; bone turnover (β-CTX and P1NP) were assessed at baseline, 2.5-h, 24-h, 48-h and 72-h following EIMD. Thirty days of Natiiv™ collagen supplementation had no significant effect on any outcome measure (P > 0.05 with small-medium effect sizes) compared to hydrolysed collagen or placebo. Future studies should explore the potential efficacy of Natiiv™ collagen supplementation in other relevant populations/scenarios and assess the post-prandial bioavailability of Natiiv™ collagen and, if impaired, explore interventions that can increase its bioavailability and optimise recovery from EIMD.
James, Thomas J.
09b6c543-c918-4e4b-9556-57bdf0e04f4c
Mayes, Harry
0d11bb97-b9e7-416c-8a3c-071f67b56b07
Alnajjar, Mohammad
fe805aef-54fb-40bf-a7c7-7b0e75494b84
Newell, Yasmin
549ab6cd-2a10-4186-966f-44bb4ac7bc95
Kohlert, Eliska
fa390ec0-3360-4e2f-a447-94f4b9ca3518
Shute, Janis
a1571be4-87e1-455f-8988-49e499c77cb6
Perissiou, Maria
ccc355db-9c02-47ae-af67-72f92df4ac1e
Corbett, Jo
f21fa7ec-9353-46c5-ac41-a88f3d163a13
Costello, Joseph T.
854fb60b-a34f-456d-b32b-c44053b111a6
Neupert, Emma
a6e4af66-f5e0-4142-83ce-a285f3181810
Moore, Joseph M.
77e426cd-73a4-42dc-84aa-2e4795facbe8
Morgan, Paul T.
d01a26fc-a263-4936-af99-7a677a5952b1
Simms, Chris
125425fe-9ef9-48e5-b9fb-32f891629133
Saynor, Zoe L.
a4357c7d-db59-4fa5-b24f-58d2f7e74e39
Shepherd, Anthony I.
80631910-b7ca-45dd-b88b-a13133105572
James, Thomas J.
09b6c543-c918-4e4b-9556-57bdf0e04f4c
Mayes, Harry
0d11bb97-b9e7-416c-8a3c-071f67b56b07
Alnajjar, Mohammad
fe805aef-54fb-40bf-a7c7-7b0e75494b84
Newell, Yasmin
549ab6cd-2a10-4186-966f-44bb4ac7bc95
Kohlert, Eliska
fa390ec0-3360-4e2f-a447-94f4b9ca3518
Shute, Janis
a1571be4-87e1-455f-8988-49e499c77cb6
Perissiou, Maria
ccc355db-9c02-47ae-af67-72f92df4ac1e
Corbett, Jo
f21fa7ec-9353-46c5-ac41-a88f3d163a13
Costello, Joseph T.
854fb60b-a34f-456d-b32b-c44053b111a6
Neupert, Emma
a6e4af66-f5e0-4142-83ce-a285f3181810
Moore, Joseph M.
77e426cd-73a4-42dc-84aa-2e4795facbe8
Morgan, Paul T.
d01a26fc-a263-4936-af99-7a677a5952b1
Simms, Chris
125425fe-9ef9-48e5-b9fb-32f891629133
Saynor, Zoe L.
a4357c7d-db59-4fa5-b24f-58d2f7e74e39
Shepherd, Anthony I.
80631910-b7ca-45dd-b88b-a13133105572

James, Thomas J., Mayes, Harry, Alnajjar, Mohammad, Newell, Yasmin, Kohlert, Eliska, Shute, Janis, Perissiou, Maria, Corbett, Jo, Costello, Joseph T., Neupert, Emma, Moore, Joseph M., Morgan, Paul T., Simms, Chris, Saynor, Zoe L. and Shepherd, Anthony I. (2025) The effect of intact vs hydrolysed collagen on recovery from exercise induced muscle damage: a double-blind, randomised, placebo-controlled trial. Journal of Nutritional Physiology, 1. (doi:10.1016/j.jnphys.2025.100003).

Record type: Article

Abstract

Collagen supplementation has the potential to aid in the recovery from exercise-induced muscle damage (EIMD). A novel collagen supplement, rich in intact type I collagen (Natiiv™, Trinsic Collagen Limited), potentially increases delivery of its constituent amino acids and intact alpha helices to the extracellular matrix (ECM) for remodelling. Thirty-six healthy, young and active adults (M = 27, age: 21.3 ± 4.3 years, body mass index; 25.2 ± 5.7 kg m−2) were assigned (1:1:1) in a double-blind, randomised, placebo-controlled trial, to consume either: Natiiv™ collagen (0.255 g·day−1 of Natiiv™ collagen), hydrolysed collagen (20 g·day−1 of collagen; Peptan®, Rousselot, Belgium), or placebo (collagen depleted alkaline water; Natiiv™), for 30-days. On day-28, muscle damage-inducing exercise (150 drop jumps) was undertaken. Exercise performance (counter movement, squat, and drop jumps), quadriceps strength (maximal voluntary isometric contraction; leg pain (visual analogue scale, pain pressure threshold, short recovery and stress scale questionnaire); and knee inflammation (via colour fraction ultrasonography) and systemic inflammation (IL-6, IL-10, TNFα); ECM damage (hydroxyproline) and; bone turnover (β-CTX and P1NP) were assessed at baseline, 2.5-h, 24-h, 48-h and 72-h following EIMD. Thirty days of Natiiv™ collagen supplementation had no significant effect on any outcome measure (P > 0.05 with small-medium effect sizes) compared to hydrolysed collagen or placebo. Future studies should explore the potential efficacy of Natiiv™ collagen supplementation in other relevant populations/scenarios and assess the post-prandial bioavailability of Natiiv™ collagen and, if impaired, explore interventions that can increase its bioavailability and optimise recovery from EIMD.

Text
ACCEPTED_-_Collagen_paper_JNP_clean - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (129kB)
Text
1-s2.0-S3050624725000038-main - Version of Record
Available under License Creative Commons Attribution.
Download (5MB)

More information

Accepted/In Press date: 13 May 2025
e-pub ahead of print date: 15 May 2025
Published date: 19 May 2025

Identifiers

Local EPrints ID: 502661
URI: http://eprints.soton.ac.uk/id/eprint/502661
PURE UUID: c57da75b-d17f-40bf-a147-344c686881cc
ORCID for Zoe L. Saynor: ORCID iD orcid.org/0000-0003-0674-8477

Catalogue record

Date deposited: 03 Jul 2025 16:53
Last modified: 22 Aug 2025 02:43

Export record

Altmetrics

Contributors

Author: Thomas J. James
Author: Harry Mayes
Author: Mohammad Alnajjar
Author: Yasmin Newell
Author: Eliska Kohlert
Author: Janis Shute
Author: Maria Perissiou
Author: Jo Corbett
Author: Joseph T. Costello
Author: Emma Neupert
Author: Joseph M. Moore
Author: Paul T. Morgan
Author: Chris Simms
Author: Zoe L. Saynor ORCID iD
Author: Anthony I. Shepherd

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×